Weight Management

 
First-in-Class Tirzepatide Wins FDA Approval for Treatment of Type 2 Diabetes
May 16, 2022

Tirzepatide, a novel once-weekly GLP-1/GIP mimetic that binds to receptors and stimulates glucose-dependent insulin release, has shown superiority over many common antihyperglycemics.

Patient-centered Treatment for Obesity: Guidelines from the Canadian Obesity Society
May 12, 2022

The Canadian Obesity Society advocates for a therapeutic approach to obesity that removes stigma, focuses on individual patient goals, and favors body health over body weight.

Study: Only 3% of Adults with Overweight or Obesity in England are Referred to Weight Management Programs by Primary Care Clinician
May 09, 2022

Women, Black individuals, and adults diagnosed with overweight or obesity in more recent years were more likely to receive a referral, according to new study.

Obesity Rose Disproportionately Among Low-income Youth During Early COVID-19
May 09, 2022

The proportion of overweight, obesity, or severe obesity increased from 38% to 45% among 4500 young people seen in a primary care network where most receive public insurance.

Adults with Asthma Found at Higher Risk for Obesity in International Study
April 29, 2022

The observational study found that longer duration of disease conferred a 32% greater risk of obesity and that nonatopic asthma carried at 47% greater risk.

Tirzepatide Yields Top Weight Loss of 20% or More in SURMOUNT Clinical Trial
April 28, 2022

Tirzepatide was associated with reductions in body weight of up to 22.5% over 72 weeks in the global phase 3 registration trial.

Pulmonary Rehab Improves Lung Function, QOL in Asthma-COPD Overlap Plus Obesity
April 25, 2022

Asthma-COPD overlap and obesity mutually exacerbate each other and an early program of pulmonary rehabilitation shows promise to help both.

Expanding Reach Beyond Clinic Walls is Essential to the Future of Health Care, says Investigator
April 15, 2022

SuperWIN trial findings suggest the future of successful health care depends on harnessing familiar, community- based resources to maintain health and deliver care.

Bodyweight Variability May Increase Risk for Major CV Events in Type 2 Diabetes Patients: New Study
March 24, 2022

Persons with type 2 diabetes who either gained or lost 5% of baseline bodyweight were found to be at higher risk for heart failure, MI, and all-cause death.

Overweight, Obesity in Midlife Tied to Higher Morbidity and Health Care Costs Later in Life
March 22, 2022

Having overweight or obesity in midlife was associated with significantly higher cumulative morbidity and health care costs during older adulthood in prospective cohort study.